Ms Milanova, now 30, got her first period at just nine but, without any education about menstruation, feared she was gravely ...

Novartis will acquire Regulus Therapeutics for up to $1.7B, boosting its kidney drug pipeline with lead candidate farabursen.

Despite the diagnosis, Valentina continued to grapple with cysts, severe pain, bloating, and heavy bleeding. Her personal ...

Novartis has agreed to buy Regulus Therapeutics for up to $1.7 billion, giving the Swiss drugmaker access to an experimental ...

Novartis has announced that it will be acquiring Regulus Therapeutics in a deal worth $1.7bn, marking a notable boost to the ...

Transaction includes USD 0.8 billion upfront with a potential additional USD 0.9 billion payment upon the achievement of a ...

The woman was in severe pain and discomfort, unable to focus on her job, eat, or sleep properly. She was exhausted, but had ...

Novartis has reached an agreement to buy Regulus Therapeutics and its experimental therapy for autosomal dominant polycystic ...

Regulus Therapeutics will be acquired by Novartis AG for $7 per share in cash. Click here for more information on RGLS ...

However, the pain worsened over time to the point where she “couldn’t leave” her bed. At the age of 11, her parents took her ...